Historical salary details - Dr. Neil Kumar, PhD, Director and Chief Executive Officer of the Company and Eidos Therapeutics, Inc., BridgeBio Pharma Inc
Dr. Neil Kumar, PhD has been the Director and Chief Executive Officer of the Company and Eidos Therapeutics, Inc. of BridgeBio Pharma Inc since 22 Feb 2015. View his historical salary.
Dr. Neil Kumar, Phd
Director and Chief Executive Officer of the Company and Eidos Therapeutics, Inc.
-
Gross Remuneration
-
Current Company
BridgeBio Pharma Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | BridgeBio Pharma Inc | Director and Chief Executive Officer of the Company and Eidos Therapeutics, Inc. | - | - |
| 2023 | BridgeBio Pharma Inc | Director and President; Chief Executive Officer of the Company and Eidos Therapeutics, Inc. | 12.2 M | 82.2 % |
| 2022 | BridgeBio Pharma Inc | Director; President and Chief Executive Officer of the Company and Eidos Therapeutics | 6.7 M | -74.0 % |
| 2021 | BridgeBio Pharma Inc | - | 25.6 M | 154.9 % |
| 2021 | BridgeBio Pharma Inc | Director; President and Chief Executive Officer of the company and Eidos Therapeutics | 25.6 M | 154.9 % |
| 2020 | BridgeBio Pharma Inc | - | 10.1 M | -61.8 % |
| 2020 | BridgeBio Pharma Inc | - | 10.1 M | -61.8 % |
| 2020 | BridgeBio Pharma Inc | Director; President and Chief Executive Officer of the company and Eidos Therapeutics | 10.1 M | -61.8 % |
| 2019 | BridgeBio Pharma Inc | - | 26.3 M | 5752.0 % |
| 2019 | BridgeBio Pharma Inc | - | 26.3 M | 5752.0 % |
| 2019 | BridgeBio Pharma Inc | Director; Chief Executive Officer of company and Eidos Therapeutics | 26.3 M | 5752.0 % |
| 2018 | BridgeBio Pharma Inc | - | 450 K | - |
| 2018 | BridgeBio Pharma Inc | - | 450 K | - |
| 2018 | BridgeBio Pharma Inc | Chief Executive Officer and Director | 450 K | - |